IFNG and cancer: (25) have identified six cancer immune subtypes (IS) including IS1 (wound healing), IS2 (IFN-γ dominant), IS3 (inflammatory), IS4 (lymphocyte depleted), IS5 (immunologically quiet), and IS6 (TGF-β dominant).